DE102004004142A1 - 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine - Google Patents

6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine Download PDF

Info

Publication number
DE102004004142A1
DE102004004142A1 DE102004004142A DE102004004142A DE102004004142A1 DE 102004004142 A1 DE102004004142 A1 DE 102004004142A1 DE 102004004142 A DE102004004142 A DE 102004004142A DE 102004004142 A DE102004004142 A DE 102004004142A DE 102004004142 A1 DE102004004142 A1 DE 102004004142A1
Authority
DE
Germany
Prior art keywords
alkyl
group
optionally
formula
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102004004142A
Other languages
German (de)
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to DE102004004142A priority Critical patent/DE102004004142A1/de
Priority to CA2524900A priority patent/CA2524900C/en
Priority to JP2006505294A priority patent/JP2006525966A/ja
Priority to US10/556,224 priority patent/US8044060B2/en
Priority to AU2004235915A priority patent/AU2004235915B2/en
Priority to EP04729876A priority patent/EP1626971B1/de
Priority to NZ543812A priority patent/NZ543812A/en
Priority to EP10186283.7A priority patent/EP2298773B1/de
Priority to PCT/EP2004/004455 priority patent/WO2004099211A1/de
Priority to CL200400978A priority patent/CL2004000978A1/es
Priority to UY28312A priority patent/UY28312A1/es
Priority to MYPI20041687A priority patent/MY148252A/en
Priority to TW093112841A priority patent/TWI350836B/zh
Priority to PE2004000472A priority patent/PE20050201A1/es
Publication of DE102004004142A1 publication Critical patent/DE102004004142A1/de
Priority to US12/950,386 priority patent/US8822479B2/en
Priority to US13/233,833 priority patent/US8642605B2/en
Priority to JP2011244500A priority patent/JP5277303B2/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE102004004142A 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine Withdrawn DE102004004142A1 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
CA2524900A CA2524900C (en) 2003-05-09 2004-04-28 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
JP2006505294A JP2006525966A (ja) 2003-05-09 2004-04-28 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類
US10/556,224 US8044060B2 (en) 2003-05-09 2004-04-28 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
AU2004235915A AU2004235915B2 (en) 2003-05-09 2004-04-28 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
EP04729876A EP1626971B1 (de) 2003-05-09 2004-04-28 6-cyclylmethyl- und 6-alkylmethyl-substituierte pyrazolopyrimidine
NZ543812A NZ543812A (en) 2003-05-09 2004-04-28 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
EP10186283.7A EP2298773B1 (de) 2003-05-09 2004-04-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
PCT/EP2004/004455 WO2004099211A1 (de) 2003-05-09 2004-04-28 6-cyclylmethyl- und 6-alkylmethyl-substituierte pyrazolopyrimidine
CL200400978A CL2004000978A1 (es) 2003-05-09 2004-05-07 Compuestos derivados de pirazolopirimidinas sustituidos de formula definida, inhibidores de pde; procedimiento para su preparacion; composicion farmaceutica que los contiene y sus usos para preparar medicamentos que sirven para tratar trastornos de l
UY28312A UY28312A1 (es) 2003-05-09 2004-05-07 Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
MYPI20041687A MY148252A (en) 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
TW093112841A TWI350836B (en) 2003-05-09 2004-05-07 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
PE2004000472A PE20050201A1 (es) 2003-05-09 2004-05-07 Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo
US12/950,386 US8822479B2 (en) 2003-05-09 2010-11-19 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
US13/233,833 US8642605B2 (en) 2003-05-09 2011-09-15 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
JP2011244500A JP5277303B2 (ja) 2003-05-09 2011-11-08 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10320784.8 2003-05-09
DE10336183.9 2003-08-07
DE10336183 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
DE102004004142A1 true DE102004004142A1 (de) 2004-11-25

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004004142A Withdrawn DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Country Status (9)

Country Link
EP (1) EP2298773B1 (cg-RX-API-DMAC10.html)
JP (1) JP5277303B2 (cg-RX-API-DMAC10.html)
CL (1) CL2004000978A1 (cg-RX-API-DMAC10.html)
DE (1) DE102004004142A1 (cg-RX-API-DMAC10.html)
MY (1) MY148252A (cg-RX-API-DMAC10.html)
NZ (1) NZ543812A (cg-RX-API-DMAC10.html)
PE (1) PE20050201A1 (cg-RX-API-DMAC10.html)
RU (1) RU2383546C2 (cg-RX-API-DMAC10.html)
TW (1) TWI350836B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2654094T3 (es) * 2013-04-05 2018-02-12 Eisai R&D Management Co., Ltd. Compuestos piridinilpirazoloquinolina
KR20200010220A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸로퀴놀린 유도체를 함유하는 루이소체 질병 치료제
BR112019023569A2 (pt) 2017-06-01 2020-06-02 Eisai R&D Management Co., Ltd. Agente terapêutico da demência combinando derivados de pirazoloquinolina e donepezila
CN116585316A (zh) 2017-06-01 2023-08-15 卫材R&D管理有限公司 包含pde9抑制剂的药物组合物
JP7177772B2 (ja) 2017-06-01 2022-11-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体とメマンチンの併用による認知症治療剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
CH396925A (de) * 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
DK0379917T3 (da) 1989-01-26 1995-12-11 Bayer Ag Optisk aktive (meth)acrylsyre-drivater, deres fremstilling, deres polymerisation til optisk aktive polymere og disses anvendelse
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
EP1307201B1 (de) * 2000-08-01 2004-11-24 Bayer HealthCare AG Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
KR20040053210A (ko) * 2001-11-02 2004-06-23 화이자 프로덕츠 인크. Pde9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Also Published As

Publication number Publication date
CL2004000978A1 (es) 2005-03-18
EP2298773A1 (de) 2011-03-23
TW200508237A (en) 2005-03-01
JP2012036221A (ja) 2012-02-23
JP5277303B2 (ja) 2013-08-28
PE20050201A1 (es) 2005-05-27
TWI350836B (en) 2011-10-21
NZ543812A (en) 2010-06-25
RU2383546C2 (ru) 2010-03-10
RU2005138339A (ru) 2006-08-10
EP2298773B1 (de) 2013-06-19
MY148252A (en) 2013-03-29

Similar Documents

Publication Publication Date Title
EP1534713B1 (de) Alkyl-substituierte pyrazolopyrimidine
EP1534711B1 (de) Phenyl-substituierte pyrazolopyrimidine
EP1626971B1 (de) 6-cyclylmethyl- und 6-alkylmethyl-substituierte pyrazolopyrimidine
EP1628980B1 (de) 6-arylmethyl-substituierte pyrazolopyrimidine
US8822479B2 (en) 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
EP1644339B1 (de) 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
JP5277303B2 (ja) 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類

Legal Events

Date Code Title Description
8181 Inventor (new situation)

Inventor name: KAMPEN, MARJA VAN, DR., 40219 DUESSELDORF, DE

Inventor name: ERB, CHRISTINA, DR., 40227 DUESSELDORF, DE

Inventor name: B?RFACKER, LARS, DR., 46149 OBERHAUSEN, DE

Inventor name: HENDRIX, MARTIN, DR., 51519 ODENTHAL, DE

Inventor name: STAAY, FRANZ-JOSEF VAN DER, DR., 53797 LOHMAR, DE

Inventor name: SCHAUSS, DAGMAR, 42697 SOLINGEN, DE

Inventor name: HECKROTH, HEIKE, DR., 42327 WUPPERTAL, DE

Inventor name: TERSTEEGEN, ADRIAN, DR., 42553 VELBERT, DE

Inventor name: HAFNER, FRANK-THORSTEN, DR., 42115 WUPPERTAL, DE

8127 New person/name/address of the applicant

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, 55218, DE

8141 Disposal/no request for examination